Daejeon, South Korea

Eok Park


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Daejeon, KR (2012 - 2014)
  • Daejeong, KR (2013 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Eok Park: Innovator in Cellular Necrosis Inhibition

Introduction

Eok Park is a prominent inventor based in Daejeon, South Korea, known for his contributions to pharmaceutical sciences. With a portfolio that includes five active patents, he is focused on developing innovative solutions for the treatment and prevention of cellular necrosis and related diseases. His work in this vital area has the potential to make significant impacts on health outcomes.

Latest Patents

Among Eok Park's latest patents are groundbreaking inventions involving indole and indazole compounds. The first patent details the use of these compounds, along with their pharmaceutically acceptable salts or isomers, as effective inhibitors of cellular necrosis. This invention not only provides a novel method for prevention or treatment but also introduces compositions containing these compounds as active ingredients. Another significant patent focuses specifically on new indole compounds, reiterating their role against cellular necrosis and associated diseases, highlighting the versatility and importance of his research.

Career Highlights

Eok Park is associated with LG Life Sciences, Limited, a company known for its commitment to advancing healthcare through innovative biopharmaceuticals. His role within the organization places him at the forefront of research and development, allowing him to contribute significantly to the field of medical science.

Collaborations

Throughout his career, Eok Park has collaborated with notable colleagues, including Soon Ha Kim and Hyoung Jin Kim. These collaborations enable a synergistic approach to research, enhancing the innovation process and allowing for shared expertise in the pursuit of transformative healthcare solutions.

Conclusion

Eok Park exemplifies the spirit of innovation within the biopharmaceutical sector. His work on indole and indazole compounds not only addresses critical health challenges but also propels advancements in the treatment of cellular necrosis. As he continues his research at LG Life Sciences, Limited, his contributions will undoubtedly inspire further breakthroughs in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…